STUDIES ON ANTIMICROBIAL AND ANTITUMOR EFFICACY OF SOME NEW DIORGANOTIN (IV) DICARBOXYLATES

In this manuscript a series of new diorganotin (IV) dicarboxylates were screened out first time for their bio medicinal activity, like antimicrobial and in-vitro antitumor activity against different pathogenic bacterial and fungal strains along with human breast and mammary cancer cell line. It was found that the compounds show remarkable antitumor efficacy and moderate antimicrobial activity against pathogenic microbial strains.